AstraZeneca Can't Block Generic Crestor: Fed. Circ.
The Federal Circuit on Thursday rejected AstraZeneca Pharmaceuticals LP's bid to bar generic versions of its cholesterol drug Crestor, finding it couldn't pursue infringement claims against generics makers that sought to...To view the full article, register now.
Already a subscriber? Click here to view full article